Aptevo Therapeutics Stock Market Value
| APVO Stock | USD 2.41 0.03 1.26% |
| Symbol | Aptevo |
Aptevo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aptevo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aptevo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aptevo Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Aptevo Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Aptevo Therapeutics or generate 0.0% return on investment in Aptevo Therapeutics over 90 days. Aptevo Therapeutics is related to or competes with Kronos Bio, Cyclerion Therapeutics, Larimar Therapeutics, Addex Therapeutics, Achilles Therapeutics, Nutriband, and Quoin Pharmaceuticals. Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for... More
Aptevo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aptevo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aptevo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 52.56 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 8.25 |
Aptevo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptevo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aptevo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Aptevo Therapeutics historical prices to predict the future Aptevo Therapeutics' volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.67) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (2.86) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aptevo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aptevo Therapeutics Backtested Returns
Aptevo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Aptevo Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptevo Therapeutics' Mean Deviation of 5.15, standard deviation of 8.16, and Risk Adjusted Performance of (0.17) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.61, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aptevo Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Aptevo Therapeutics is expected to be smaller as well. At this point, Aptevo Therapeutics has a negative expected return of -0.65%. Please make sure to confirm Aptevo Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Aptevo Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Aptevo Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Aptevo Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aptevo Therapeutics price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Aptevo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.34 |
Aptevo Therapeutics lagged returns against current returns
Autocorrelation, which is Aptevo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aptevo Therapeutics' stock expected returns. We can calculate the autocorrelation of Aptevo Therapeutics returns to help us make a trade decision. For example, suppose you find that Aptevo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aptevo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aptevo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aptevo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aptevo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Aptevo Therapeutics Lagged Returns
When evaluating Aptevo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aptevo Therapeutics stock have on its future price. Aptevo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aptevo Therapeutics autocorrelation shows the relationship between Aptevo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Aptevo Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Aptevo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptevo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Aptevo Stock
Moving against Aptevo Stock
| 0.4 | ETON | Eton Pharmaceuticals | PairCorr |
| 0.39 | PFE | Pfizer Inc | PairCorr |
| 0.37 | MGTX | MeiraGTx Holdings PLC Downward Rally | PairCorr |
| 0.35 | LLY | Eli Lilly | PairCorr |
The ability to find closely correlated positions to Aptevo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptevo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptevo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptevo Therapeutics to buy it.
The correlation of Aptevo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptevo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptevo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptevo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aptevo Therapeutics Correlation, Aptevo Therapeutics Volatility and Aptevo Therapeutics Alpha and Beta module to complement your research on Aptevo Therapeutics. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.